News
WHO: Smoking cessation reduces risk of type 2 diabetes up to 40%
- Author:
- Nancy A. Melville
Key misconceptions among smokers with type 2 diabetes that can prevent cessation include concerns about post-cessation weight gain, the influence...
News
Newly approved myasthenia gravis drug shows sustained benefits in early responders
- Author:
- Nancy A. Melville
“This self-administered medication allows patients to be more independent and can even travel since it is not dependent on an infusion center.”
News
Chemotherapy-induced peripheral neuropathy tied to compromised executive function
- Author:
- Nancy A. Melville
Chemotherapy-related mobility declines in CIPN survivors are likely due to both neuromuscular and executive dysfunction.
News
First new treatment in 30 years for rare disease is effective, tolerable, convenient
- Author:
- Nancy A. Melville
A new subcutaneous injectable showed efficacy and tolerability in patients with chronic inflammatory demyelinating polyneuropathy.
News
Duchenne muscular dystrophy gene therapy safe, effective at 4 years
- Author:
- Nancy A. Melville
“What’s really striking, and in my mind the most impressive, is that when you follow these patients out 3 or 4 years ... you see there is this...
News
PD-1 inhibitor improves outcomes in NHL subtype
- Author:
- Nancy A. Melville
With toripalimab and radiotherapy, progression-free survival at 2 years is high for extranodal NK/T-cell lymphoma in those who respond poorly to...
News
Ocular MALT lymphoma: Radiation reduces relapse
- Author:
- Nancy A. Melville
Mortality rates from early-stage ocular MALT lymphoma are low, with relapse rates lowered by radiation therapy.
News
Nonsurgical option for more large thyroid nodule patients?
- Author:
- Nancy A. Melville
The implication is that nonsurgical options such as radiofrequency ablation may be appropriate for more patients than realized.
News
Thyroid cancer increase observed in transgender female veterans
- Author:
- Nancy A. Melville
“I would characterize the trends in our data as being potentially suggestive or hypothesis generating – not conclusive.”
News
Hold blood thinners during thyroid nodule biopsy?
- Author:
- Nancy A. Melville
“While we can never assume that [the events occurred] because the blood-thinner therapy was held, the timing within 48 hours is certainly very...
News
Triple therapy boosts anaplastic thyroid cancer survival
- Author:
- Nancy A. Melville
"The very long median overall survival in the study's neoadjuvant group is quite remarkable for a group of patients who used to have a very poor...
News
What potential does AI offer for endocrinology?
- Author:
- Nancy A. Melville
“A typical indication is fracture detection, not in terms of replacing expert radiologists or orthopedists but rather in terms of supporting those...
News
Dispelling clinicians’ misconceptions about sickle cell disease
- Author:
- Nancy A. Melville
Among clinicians and their patients, widespread myths about sickle cell disease can stand in the way of adequate treatment.
News
Pediatrician with SCD gives her young patients hope
- Author:
- Nancy A. Melville
A Nigerian-American hematologist draws on her experience living with sickle cell disease to encourage child patients and advise colleagues.
News
Adhering to endocrine therapy is hard. What can be done?
- Author:
- Nancy A. Melville
Given the array of potential obstacles to endocrine therapy adherence, improving long-term use may be equally complex.